Pyridazino-Indoles as Phenol Bioisosteres for Potent Inhibition of NLRP3
Authors: Bouche, L; Mesch, S; Steiner, S; Guba, W; Paehler, A; Tosstorff, A; Schnider, C; Patiny-Adam, A; Marx, A; Mracsko, E Z; Hendrick, A G; Rigo, P; Schlicht, S; Classen, M; Siegrist, Y-M; Kovacik, L; Clairfeuille, T; Jaeschke, G
Source journal: ACS medicinal chemistry letters (2026-11-12)
DOI: 10.1021/acsmedchemlett.6c00422
Abstract
Aberrant activation of the NLRP3 (NACHT, LRR, and PYD domain-containing protein 3) inflammasome drives chronic diseases, necessitating robust therapeutic inhibitors. Despite the promise of phenol-based pyridazines, we sought to evaluate the possibility of replacing the phenol moiety. This article presents the medicinal chemistry efforts leading to the discovery of pyridazino-indoles as potent phenol bioisosteres. These findings are based upon prior work, initially and to the best of our knowledge first disclosed in our Roche patent application published in 2023. Using cryo-EM and molecular modeling, we rationalized the binding mode, ensuring the indole scaffold maintained critical interactions, specifically with Ala228. The resulting lead indole compounds, 13 and 15, achieved single-digit nanomolar potency with excellent solubility, permeability and were profiled in mouse in vivo PK studies. Although hERG inhibition was identified as a safety concern and a reason for discontinuing their development, these novel indoles remain high-quality in vivo tool compounds. We report here the first comprehensive safety audit of the pyridazino-indoles, mapping reactive metabolite pathways.
Related topics
Related open access articles
- Molecular and Thermodynamic Modeling of the Protein-Ligand Interaction. Application to Computer-Assisted Design of Anti-Competitive Inhibitors of Human Histone Deacetylase 2 (HDAC2).
- Conformational analysis and molecular design of anthranilic acid derivatives as partial agonists of the Farnesoid X Receptor (FXR) with favorable predicted pharmacokinetic profiles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- THEORETICAL INVESTIGATION OF β-CYCLODEXTRIN WITH PYRAZOLINE DERIVATIVE
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- Molecular modeling of the multiple-drug resistant protein (MRP7) and pharmacophore modelling based virtual screening to identify novel drugs against cancer
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.